-
onlineroulettebonus| Microcore Biotech (688321.SH): Application for the III clinical trial of cidabenide in the treatment of colorectal cancer accepted
-
gameswithcrypto| ST Zhizhi (603869.SH): Xinao Xinzhi plans to increase its stake by 50 million yuan to 100 million yuan
-
goldmegawaysbigtimegaming| Tianyuan Environmental Protection: Strengthen communication with investors and improve corporate governance and overall value of the company
-
abugarciablackmax3bmax3| Lianhua Supermarket (00980.HK): It plans to issue no more than 360 million new domestic shares to Bailian Group to raise approximately 360 million yuan
-
luckylotteriessuperjackpot| ST Zhizhi: Shareholder Xinao Xinzhi plans to increase its stake in the company by 50 million yuan to 100 million yuan
-
blueprintmegaways| Zhongke Lanxun (688332.SH): 2023 annual equity distribution of 10 shares of 8.3 yuan, equity registration May 16
-
ultimatexpokerfreeharrah's| Special message: Prior notification of administrative penalty and market ban
-
freeonlinepokergames| Microchip Biology: Application for Phase III clinical trial of cidabenide for the treatment of colorectal cancer accepted
-
pursuitiii| Cook's CEO may hand it over to Apple's "own"
-
onlinepokerroulette| What is the mysterious new product of Google OpenAI? Latest guess: Multimodal AI assistant